Multisystem Inflammatory Syndrome in Children (MIS-C): Signs, symptoms? Is it a serious condition than Covid?
New Delhi, May 21: Multisystem inflammatory syndrome in children (MIS-C) is a serious condition that appears to be linked to coronavirus disease 2019 (COVID-19). Most children who become infected with the COVID-19 virus have only a mild illness.
But in children who go on to develop MIS-C, some organs and tissues - such as the heart, lungs, blood vessels, kidneys, digestive system, brain, skin or eyes - become severely inflamed.
Signs and symptoms depend on which areas of the body are affected.
Early signs of improvement in COVID-19 situation claims govt, too early to conclude say experts
MIS-C is considered a syndrome - a group of signs and symptoms, not a disease - because much is unknown about it, including its cause and risk factors. Identifying and studying more children who have MIS-C may help to eventually find a cause.
MIS-C: Symptoms
Signs and symptoms of multisystem inflammatory syndrome in children (MIS-C) include
- Fever that lasts 24 hours or longer
- Vomiting
- Diarrhea
- Pain in the stomach
- Skin rash
- Feeling unusually tired
- Fast heartbeat
- Rapid breathing
- Red eyes
- Redness or swelling of the lips and tongue
- Redness or swelling of the hands or feet
- Headache, dizziness or lightheadedness
- Enlarged lymph nodes
Emergency warning signs of MIS-C
- Severe stomach pain
- Difficulty breathing
- Pale, gray or blue-colored skin, lips or nail beds - depending on skin tone
- New confusion
- Inability to wake up or stay awake
How to prevent
- Keep hands clean
- Avoid people who are sick
- Practice social distancing at least 6 feet (2 meters) from other people
- Wear cloth face masks in public settings
- Avoid touching your nose, eyes and mouth
- Cover your mouth with a tissue or your elbow when you sneeze or cough
- Clean and disinfect high-touch surfaces every day
- Wash clothing and other items as needed
What we don't know about MIS-C
The exact cause of MIS-C is not known yet, but it appears to be an excessive immune response related to COVID-19. We also do not know if children with certain health conditions are more likely to get MIS-C. The U.S. Centers for Disease Control and Prevention (CDC) and the National Institutes of Health are working with doctors and researchers across the country to learn more about risk factors for MIS-C, share data, and improve diagnosis and treatment of MIS-C.